Skip to content
healthcare.dev

Tretinoin

NDC 62032-413, Tretinoin, gel, from Obagi Cosmeceuticals LLC.

Product NDC
62032-413
Status
Listed
Labeler
Obagi Cosmeceuticals LLC
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62032-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRETINOIN.05 g/100g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
62032-413-206203204132020 g in 1 TUBE (62032-413-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b

Use it

Look up 62032-413 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62032-413 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62032-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.